Cabozantinib Bests Everolimus in RCC with Bone Metastases (CME/CE)

(MedPage Today) -- Subgroup analysis of METEOR trial showed improved survival
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news